T1	Participants 464 532	A randomized controlled trial was done of consecutive older patients
T2	Participants 624 632	Patients
T3	Participants 816 925	One hundred seventy-five eligible patients (mean age 73 +/- 10 years; 60% women) were randomized to the trial
T4	Participants 1079 1103	paced patients 216 falls
T5	Participants 1020 1028	controls
T6	Participants 1137 1151	paced patients
T7	Participants 1422 1431	controls.
